|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||107.69 / 129.00|
The U.S. Centers for Disease Control and Prevention says 91 Americans die every day as a result of an overdose.
Alphabet's top line could take a hit in 2017 as a result of AT&T, Verizon and other advertisers pulling ads from YouTube.
Annuities are in the news as Trump's appointee to head the Department of Labor spars with Sen. Warren. Here's what investors need to know.
With a 100-plus-year history, generous dividend, and diversified portfolio, could this Big Pharma player be resistant to Trump's drug price twitterstorm?
Wall Street could be in for a rocky week in the wake of the Republicans' failure to repeal and replace Obamacare as promised.
Google faces some tough decisions as the boycott of its YouTube network by advertisers continues to grow.
As long as consumers keep going to YouTube, Google's multi-billion dollar ad business shouldn't be affected by the recent push back from advertisers, according to a Pacific Crest analyst.
The Alphabet unit can't just 'put a band aid' on advertisers' concerns, lest it risk damaging its second-largest source of advertising revenue growth.
YouTube has the resources and tools to deal with its extremist content problem. And top brands have big incentives to keep spending on the site.
While it's tempting for consumers to spend their tax refund, investing their tax dollars in an IRA or stocks now can generate a substantial amount of savings.
Both Verizon Communications and AT&T stated Wednesday that each would suspend digital ads on YouTube.
Britain is the second largest market for Google, generating $7.8 billion primarily from advertising in 2016.
The GOP is scrambling for votes on Obamacare Repeal.
Abbott Laboratories appears poised to enjoy a fruitful year, though its litigation with former takeover target Alere could hold it back.
A study of analyst recommendations at the major brokerages shows that Johnson & Johnson is the #21 broker pick, on average, out of the 30 stocks making up the Dow Jones Industrial Average, according to ETF Channel. Within the broader S&P 500, when components were ranked in terms of analyst favorites, JNJ claims the #347 spot.
The top 64 companies taking a trip to TheStreet's 2017 Market Bracket Challenge tournament.
Competition Part of Company's Eighty-Five Year Commitment to Supporting Entrepreneurs, Science Education Opportunities, and Health Systems Across the Continent
Agreement gives Ortho expanded distribution rights in Europe for the NephroCheck Test on the Astute140 platform
Female representation among the top 10% of earners at the NAFE top companies increased 2% to 41%, the highest since 2013.
Where should you put your money in March? TheStreet has the strategies and analysis to help guide your investment moves for the month.
Bigger deficits will only add to inflationary pressures, boosting precious metals.
To put it simply, Stanley Black & Decker and Thermo Fisher screwed up.
Investors are deciding what to make of an impending overhaul of the American health care system in the wake of legislative progress out of Washington.
Bull market number one, perhaps of all time: the financials.
Small-caps love lower corporate taxes and higher import duties.